Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 88Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Frontline

PharmaCompass

01

Brand Name : Frontline

Fipronil

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Frontline

arrow
Pharmtech & Ingredients
Not Confirmed

Fipronil

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 484

2019 Revenue in Millions : 451

Growth (%) : 7

blank

02

Brand Name : Frontline

Fipronil

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Frontline

arrow
Pharmtech & Ingredients
Not Confirmed

Fipronil

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 460

2020 Revenue in Millions : 484

Growth (%) : 3

blank

03

Brand Name : Frontline

Fipronil

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Frontline

arrow
Pharmtech & Ingredients
Not Confirmed

Fipronil

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 435

2021 Revenue in Millions : 460

Growth (%) : -6

blank

04

Brand Name : Frontline

Fipronil

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Frontline

arrow
Pharmtech & Ingredients
Not Confirmed

Fipronil

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 433

2022 Revenue in Millions : 435

Growth (%) : 1

blank

05

Brand Name : Frontline

Fipronil

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Frontline

arrow
Pharmtech & Ingredients
Not Confirmed

Fipronil

Main Therapeutic Indication : Parasitic Infections

Currency : USD

2018 Revenue in Millions : 451

2017 Revenue in Millions : 453

Growth (%) : -0.40%

blank

06

Brand Name : Frontline

Fipronil

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Frontline

arrow
Pharmtech & Ingredients
Not Confirmed

Fipronil

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 413

2018 Revenue in Millions : 435

Growth (%) : -5

blank